Hemophagocytic lympohistiocytosis (HLH) syndrome – Primary HLH
Do Not Use
For the following indications, there is insufficient or no evidence to support the use of IG. Alternatives to IG are often available.
Recommendations | Immunomodulatory doses of IVIG are not recommended for the treatment of Primary HLH. |